Ortikos (budesonide)

Manufacturer:
misc.
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    • treatment of mild to moderate active Crohn’s disease involving the ileum and/or the ascending colon in patients 8 years and older

    Conditions:

    • Crohn’s Disease

    Therapeutic Area:

    • Gastroenterology